ROUNDUP: Israeli clinic begins study for fourth corona vaccination

Monday, 12/27/2021 9:52 AM from


| Views: 63

The flag of Israel.

TEL AVIV (dpa-AFX) – According to its own information, an Israeli hospital will begin a study for the fourth vaccination against the corona virus on Monday. Around 150 medical workers at the clinic, who had received their third vaccination by August 20, would receive another dose, the Shiba Hospital near Tel Aviv announced on Sunday evening. All of them would have had low levels of antibodies in a serological test – below 700. According to the hospital, this is the first study of its kind in the world.

A spokesman for the hospital confirmed that the vaccine from Pfizer was used for the study /Biontech used. Gili Regev-Jochai, director of the Infectious Diseases Department, said, “In this study we will review what the impact of the fourth vaccination is on antibody counts, disease prevention, and we will monitor safety.”

In view of the spread of the omicron variant of the coronavirus, Israel had already announced last week that people over 60 should receive a fourth dose of vaccine. A government panel of experts also recommended that health care workers should also be vaccinated for the fourth time. The spokesman for the Schiba Hospital said, however, that a national vaccination campaign for the fourth vaccination would only start after the first results of the study were available.


Further up?


The base prospectus as well as the final terms and the key information sheets are available here: VX42Q7,VQ9FZS,. Also note the further notes to this advertisement. The issuer is entitled to terminate securities with an open-end term.


Subscribe to more news for free

ARIVA.DE publishes analyzes, columns and news from various sources in this section. ARIVA.DE AG is not responsible for content that is recognizably posted by third parties in the “News” area of ​​this website and does not adopt it as its own. This content can be identified in particular by a corresponding “from” label below the article heading and / or by the link “To read the full article, please click here.”; The named third party is solely responsible for this content.

Other users were also interested in this article:

Leave A Comment